Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
Akumin Appoints President and Chief Operating Officer
Akumin, a national partner of choice for U.S. hospitals, health systems and physician groups, with […]
Charter Healthcare Names New CEO and COO
Charter Healthcare, the post-acute provider platform of Pharos Capital Group, LLC, announced today that it […]
enGene Appoints Alex Nichols, PhD as President and Chief Operating Officer
enGene, a clinical-stage biotechnology company pioneering novel non-viral gene therapies for local administration into mucosal […]
Optibrium Appoints Steve Yemm as Chief Commercial Officer
Optibrium, a leading developer of software and AI solutions for drug discovery, today announced the […]
BICO Group Appoints Marius Balger as New COO
BICO Group is pleased to announce the appointment of Marius Balger as Chief Operating Officer […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more